Latest Capital Markets News

AdAlta Limited has bolstered its leadership team and progressed its 'East to West' cellular therapy strategy alongside its lead drug candidate AD-214, despite a tightening cash position. The company’s recent non-binding term sheet and new clinical data signal promising momentum in its biotech pipeline.

Weebit Nano has solidified its position in the semiconductor memory sector by signing a major licensing agreement with onsemi and raising A$50 million in capital. The company is well-funded and advancing multiple commercial and technical milestones.

Dalaroo Metals advances its Lyons River Project with promising diamond drilling results confirming Broken Hill Type mineralisation and reports high-grade copper assays. The company also appoints Michael Brown as new MD and CEO, signaling a strategic push forward.

Mount Ridley Mines has completed a 1-for-10 capital consolidation and refreshed its board with experienced new directors, positioning itself for strategic growth amid ongoing portfolio evaluations.

MTM Critical Metals reported major progress in its Flash Joule Heating technology and secured $15.5 million in capital raises, positioning itself for commercialisation and strategic growth in critical metals recovery.

Titan Minerals Limited has entered an underwriting agreement with CPS Capital Group to cover a $2.8 million options shortfall, ensuring funding for its Dynasty Gold Project and working capital needs.

Equity Story Group Ltd (ASX:EQS) reports a robust December quarter marked by significant growth in funds under management, membership fees, and capital markets revenue, alongside strategic cost reductions positioning the company for sustained 2025 growth.

KneoMedia reports a successful quarter marked by significant capital raises and expanding deployments of its KneoScience platform across New York City schools, positioning the company for sustained revenue growth.

Magnum Mining and Exploration Limited moves forward with acquiring two promising rare earth element projects in Brazil while progressing negotiations on a green pig iron venture in Saudi Arabia.

Zenith Minerals reported a 40% increase in its Dulcie Far North gold resource and secured A$2.48 million in new funding, positioning the company for aggressive exploration across its Australian gold and lithium projects.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.

NSX Limited reports a $1.6 million cash injection from ISXFEU, completes the ClearPay joint venture sale, and reduces operational costs in its 2Q25 activities report, while facing delays in share issuance approval.